Made in JAPAN
Released on November 01, 2021
2capsules / 1day
5-ALA (5-aminolevulinic acid): 100mg
NMN (β-Nicotinamide mononucleotide): 100mg
with water at a convenient timing.
On February 08, 2021, Japan's [Nagasaki University] announced that 5-ALA (5-aminolevulinic acid) has a strong infection-suppressing effect on COVID-19.
For details, please refer to the URL below.
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro
The study was conducted in vitro and the effects of oral inoculation as a supplement are still being tested.
5-ALA is an amino acid originally present in the human body, but it decreases after peaking at the age of 17.
Ingesting 10 mg of 5-ALA in food requires at least 50 kg of spinach, at least 102 kg of tomatoes, or at least 5.8 liters of wine.
NMN is a precursor of NAD+. NMN was discovered in 2011 by Shin-ichiro Imai M.D., Ph.D.Professor of the University of Washington and others for its anti-aging effect.
It provides energy to all seven types of sirtuin genes (longevity genes).
Experiments with mice have confirmed rejuvenation from 60 to 20 years of age in humans. In addition, it has been confirmed that weight gain is suppressed by promoting metabolism.
For example, when the sirtuin gene No. 1 is activated.
Liver: Decomposition of fatty acids.
Brain: nerve protection
Heart: Inflammation relief / cardioplegia
Pancreas: Insulin secretion
When sirtuin gene No. 5 is activated.
Liver: Increased production of urea
When sirtuin gene No. 6 is activated.
DNA: Damage repair
When sirtuin gene No. 7 is activated.
Heart: Improved stress tolerance
The above improvements are expected.
NMN is approved as a food ingredient in Japan. A study by Keio University has also confirmed that humans can safely take NMN orally.